MedPath
NMPA Approval

Paracetamol for Suspension

国药准字H20053008

April 13, 2020

Drug Information

对乙酰氨基酚干混悬剂

宜利妙

宜利妙

口服混悬剂

1.01g:0.3g

化学药品

April 13, 2020

Company Information

Applicant Company

山东省青岛市城阳区凤锦路16号

Manufacturing Company

山东省青岛市城阳区凤锦路16号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

对乙酰氨基酚干混悬剂 - NMPA 批准文号 | MedPath